D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FAZE
3251
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $1.28M | ﹤0.01% |
+131,687
| New | +$1.28M |
|
3252
Pliant Therapeutics
PLRX
$65M
| $1.28M | ﹤0.01% |
75,994
-13,727
| -15% | -$291K |
|
|
K
3253
PUT
DELISTED
Kellanova
K
| $1.28M | ﹤0.01% |
21,300
-4,793
| -18% | -$287K |
|
3254
Mueller Industries
MLI
$14.5B
| $1.28M | ﹤0.01% |
124,424
+93,508
| +302% | +$1,000K |
|
|
RAD
3255
PUT
DELISTED
Rite Aid Corporation
RAD
| $1.28M | ﹤0.01% |
90,000
| – | – |
|
3256
PUT
Ascendis Pharma A/S
ASND
$16.5B
| $1.27M | ﹤0.01% |
8,000
| – | – |
|
|
ENVXW
3257
DELISTED
Enovix Corporation Warrant
ENVXW
| $1.27M | ﹤0.01% |
145,901
| – | – |
|
|
CBAY
3258
DELISTED
Cymabay Therapeutics
CBAY
| $1.27M | ﹤0.01% |
348,698
-248,029
| -42% | -$977K |
|
3259
CALL
Hershey
HSY
$37.3B
| $1.27M | ﹤0.01% |
7,500
-25,000
| -77% | -$4.42M |
|
|
PACW
3260
PUT
DELISTED
PacWest Bancorp
PACW
| $1.27M | ﹤0.01% |
28,000
| – | – |
|
3261
Biglari Holdings Class B
BH
$1.2B
| $1.27M | ﹤0.01% |
7,378
-14
| -0.2% | -$2.35K |
|
3262
Liberty Media Series A
FWONA
$23.4B
| $1.27M | ﹤0.01% |
28,108
-31,336
| -53% | -$1.31M |
|
|
REGI
3263
PUT
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.26M | ﹤0.01% |
+25,200
| New | +$1.38M |
|
|
WPRT
3264
Westport Fuel Systems
WPRT
$31.9M
| $1.26M | ﹤0.01% |
38,400
+15,739
| +69% | +$634K |
|
3265
PUT
Herbalife
HLF
$1.3B
| $1.26M | ﹤0.01% |
+29,700
| New | +$1.47M |
|
3266
Madison Square Garden
MSGS
$9.59B
| $1.26M | ﹤0.01% |
6,758
-2,245
| -25% | -$384K |
|
3267
Euronet Worldwide
EEFT
$3.19B
| $1.26M | ﹤0.01% |
9,868
-40,906
| -81% | -$5.43M |
|
3268
McGrath RentCorp
MGRC
$2.87B
| $1.25M | ﹤0.01% |
+17,432
| New | +$1.28M |
|
3269
PUT
EQT Corp
EQT
$32.9B
| $1.25M | ﹤0.01% |
61,200
-2,500
| -4% | -$48.4K |
|
3270
CALL
Centene
CNC
$30.5B
| $1.25M | ﹤0.01% |
20,000
-40,000
| -67% | -$2.67M |
|
|
ZH
3271
Zhihu
ZH
$288M
| $1.24M | ﹤0.01% |
+22,471
| New | +$1.35M |
|
3272
Advanced Energy
AEIS
$10.1B
| $1.24M | ﹤0.01% |
14,167
+6,750
| +91% | +$631K |
|
3273
AngloGold Ashanti
AU
$39.4B
| $1.24M | ﹤0.01% |
77,649
-896,574
| -92% | -$15.5M |
|
3274
NexGen Energy
NXE
$5.91B
| $1.24M | ﹤0.01% |
+261,400
| New | +$1.16M |
|
3275
PUT
Louisiana-Pacific
LPX
$5.14B
| $1.24M | ﹤0.01% |
+20,200
| New | +$1.19M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.